Psychiatric Comorbidities and Risks of Death, Non-Fatal Overdose, and Self-Harm in Opioid Agonist Therapy: A Retrospective Cohort Study

Introduction

Psychiatric disorders are common among patients with opioid use disorder (OUD). Opioid agonist therapy (OAT) is an effective treatment for OUD, but outcomes for patients with psychiatric comorbidities remain understudied. This study aimed to examine the connections between psychiatric comorbidities and outcomes in individuals undergoing OAT.